Parental Perceptions of the Efficacy of Methylphenidate on Health-Related Quality of Life in Survivors of Paediatric Brain Tumour
Psychoactives · 2022
DOI: 10.3390/psychoactives1010004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychoactives, 2022. Verfasst von Lauren Smith und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Survivors of pediatric brain tumor experience substantial post-treatment challenges, facing greater cognitive impairment and lower Health-Related Quality of Life (HRQoL) compared to survivors of other childhood cancers. Early studies report methylphenidate to benefit cognition and HRQoL in paediatric survivors of cancer via improved processing speed and attention. Parental opinion is an important element of treatment decision making, however parents’ views on methylphenidate treatment have not been reported. This study explored parental perceptions of their child’s treatment with methylphenidate. Materials and methods: An evaluation of 10 parents of children with previous brain tumour receiving methylphenidate was performed. Data were gathered by qualitative parental-report HRQoL questionnaire (PedsQL parent form) and by a questionnaire developed for use in this population.
Results
Preliminary data suggest that parents are positive about the use of methylphenidate as an interventional measure, and believed this to have a beneficial impact on their child’s HRQoL.
Conclusion
Early data from a small sample of parents suggest that methylphenidate may be effective in supporting HRQoL within this population. Parental information supports an increasing evidence base for the benefits of methylphenidate as an intervention for the management of long-term difficulties associated with paediatric cancer.
Zitieren
APA
Smith, L., & Verity, S. J. (2022). Parental Perceptions of the Efficacy of Methylphenidate on Health-Related Quality of Life in Survivors of Paediatric Brain Tumour. Psychoactives. https://doi.org/10.3390/psychoactives1010004
Vancouver
Smith L, Verity SJ. Parental Perceptions of the Efficacy of Methylphenidate on Health-Related Quality of Life in Survivors of Paediatric Brain Tumour. Psychoactives. 2022. doi:10.3390/psychoactives1010004
BibTeX
@article{Smith2022,
author = {Smith, Lauren and Verity, Sarah J.},
title = {Parental Perceptions of the Efficacy of Methylphenidate on Health-Related Quality of Life in Survivors of Paediatric Brain Tumour},
journal = {Psychoactives},
year = {2022},
doi = {10.3390/psychoactives1010004}
}
EUVIMED